Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTT-851 in Type 2 Diabetes Mellitus
NCT01699737Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Sep 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JTT-851 in type 2 diabetes mellitus (T2DM), sponsored by Akros Pharma Inc.. Started Sep 2012; status: completed.
02
Drugs
JTT-851
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01699737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01699737.